Ed Hrubiec is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as the Regional Business Director for the Northeast at ITF Therapeutics LLC, specializing in pediatric neuromuscular rare diseases. Previous roles include Regional Access Manager and Regional Business Director at Amylyx Pharmaceuticals, where responsibilities encompassed market access and sales leadership for rare diseases. Ed's extensive experience includes positions at Intercept Pharmaceuticals, AbbVie, Vertex Pharmaceuticals, Gilead Sciences, and Abbott, focusing on access management, specialty sales, and key account management across various therapeutic areas. Ed holds a Bachelor of Science in Applied Professional Sciences with a minor in Business Marketing from the University of South Carolina.